{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:56:25Z","timestamp":1790139385384,"version":"4.0.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1R01GM130941-01"],"award-info":[{"award-number":["1R01GM130941-01"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1R35GM149321"],"award-info":[{"award-number":["1R35GM149321"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["PR221368"],"award-info":[{"award-number":["PR221368"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002886","name":"Foundation for Ichthyosis and Related Skin Types","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jconrel.2024.05.003","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T13:45:05Z","timestamp":1715780705000},"page":"626-642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["\u201cClick\u201d amphotericin B in prodrug nanoformulations for enhanced systemic fungemia treatment"],"prefix":"10.1016","volume":"370","author":[{"given":"Dandan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liye","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dekai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"165","key":"10.1016\/j.jconrel.2024.05.003_bb0005","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2024.05.003_bb0010","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41577-022-00826-w","article-title":"Immune responses to human fungal pathogens and therapeutic prospects","volume":"23","author":"Lionakis","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.jconrel.2024.05.003_bb0015","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1469-0691.2009.02929.x","article-title":"Trends in invasive fungal infections, with emphasis on invasive aspergillosis","volume":"15","author":"Erjavec","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.003_bb0020","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd.2017.46","article-title":"The antifungal pipeline: a reality check","volume":"16","author":"Perfect","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2024.05.003_bb0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","article-title":"Sixty years of amphotericin B: an overview of the main antifungal agent used to treat invasive fungal infections","volume":"10","author":"Cavassin","year":"2021","journal-title":"Infect. Dis. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.003_bb0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.riam.2009.06.003","article-title":"Amphotericin B: side effects and toxicity","volume":"26","author":"Laniado-Labor\u00edn","year":"2009","journal-title":"Rev. Iberoam. Micol."},{"key":"10.1016\/j.jconrel.2024.05.003_bb0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1016243313027","article-title":"Comparative tissue distribution and elimination of amphotericin B colloidal dispersion (Amphocil\u00ae) and Fungizone\u00ae after repeated dosing in rats","volume":"12","author":"Wang","year":"1995","journal-title":"Pharm. Res."},{"issue":"12","key":"10.1016\/j.jconrel.2024.05.003_bb0040","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/AAC.45.12.3487-3496.2001","article-title":"Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with aspergillus species and other filamentous fungi: maximum tolerated dose study","volume":"45","author":"Walsh","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2024.05.003_bb0045","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","article-title":"Liposomal amphotericin B (AmBisome\u00ae): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions","volume":"76","author":"Stone","year":"2016","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.jconrel.2024.05.003_bb0050","doi-asserted-by":"crossref","first-page":"e1845","DOI":"10.1016\/S2214-109X(22)00450-8","article-title":"Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial","volume":"10","author":"Lawrence","year":"2022","journal-title":"Lancet Glob. Health"},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.003_bb0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41565-021-00866-8","article-title":"Nanotechnology approaches for global infectious diseases","volume":"16","author":"Kirtane","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2024.05.003_bb0060","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jconrel.2014.03.055","article-title":"Lipid and polymer nanoparticles for drug delivery to bacterial biofilms","volume":"190","author":"Forier","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.05.003_bb0065","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.ijbiomac.2014.10.014","article-title":"Amphotericin-B entrapped lecithin\/chitosan nanoparticles for prolonged ocular application","volume":"72","author":"Chhonker","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.003_bb0070","first-page":"252","article-title":"Development, characterization, and toxicity evaluation of amphotericin B\u2013loaded gelatin nanoparticles, nanomedicine: nanotechnology","volume":"4","author":"Nahar","year":"2008","journal-title":"Biol. Med."},{"issue":"19","key":"10.1016\/j.jconrel.2024.05.003_bb0075","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1039\/C7TB00701A","article-title":"Switchable release nano-reservoirs for co-delivery of drugs via a facile micelle\u2013hydrogel composite","volume":"5","author":"Patel","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2024.05.003_bb0080","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s11095-009-9841-2","article-title":"Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone\u00ae","volume":"26","author":"Italia","year":"2009","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.003_bb0085","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1021\/acs.molpharmaceut.2c01087","article-title":"Engineering Telodendrimer Nanocarriers for monomeric amphotericin B delivery","volume":"20","author":"Ji","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.05.003_bb0090","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejps.2018.01.017","article-title":"Amphotericin B-albumin conjugates: synthesis, toxicity and anti-fungal activity","volume":"115","author":"Gurudevan","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.003_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152112","article-title":"Characterization of a polyethylene glycol-amphotericin B conjugate loaded with free AMB for improved antifungal efficacy","volume":"11","author":"Tan","year":"2016","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.003_bb0100","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.201655","article-title":"Branched amphotericin functional poly (N-iso propyl acrylamide): an antifungal polymer","volume":"8","author":"Swift","year":"2021","journal-title":"Royal Society Open Science"},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.003_bb0105","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ajps.2022.04.007","article-title":"Amphotericin B release rate is the link between drug status in the liposomal bilayer and toxicity","volume":"17","author":"Svirkin","year":"2022","journal-title":"Asian Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.jconrel.2024.05.003_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jddst.2017.02.010","article-title":"Anti-fungal and anti-leishmanial activities of pectin-amphotericin B conjugates","volume":"39","author":"Kothandaraman","year":"2017","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.003_bb0115","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0142-9612(01)00251-4","article-title":"Synthesis and characterization of novel water soluble amphotericin B\u2013arabinogalactan conjugates","volume":"23","author":"Ehrenfreund-Kleinman","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.05.003_bb0120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.actbio.2016.09.036","article-title":"Biodegradable functional polycarbonate micelles for controlled release of amphotericin B","volume":"46","author":"Wang","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2024.05.003_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104225","article-title":"Phenylboronic acid-installed poly (isobutene-alt-maleic anhydride) polymeric micelles for pH-dependent release of amphotericin B","volume":"81","author":"Song","year":"2023","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"12","key":"10.1016\/j.jconrel.2024.05.003_bb0130","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1002\/ange.201510321","article-title":"Fast and tight boronate formation for click bioorthogonal conjugation","volume":"128","author":"Akgun","year":"2016","journal-title":"Angew. Chem."},{"issue":"40","key":"10.1016\/j.jconrel.2024.05.003_bb0135","doi-asserted-by":"crossref","first-page":"14285","DOI":"10.1021\/jacs.7b08693","article-title":"Synergic \u201cclick\u201d boronate\/thiosemicarbazone system for fast and irreversible bioorthogonal conjugation in live cells","volume":"139","author":"Akgun","year":"2017","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.jconrel.2024.05.003_bb0140","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1021\/jo01088a011","article-title":"Polyol complexes and structure of the benzeneboronate ion","volume":"24","author":"Lorand","year":"1959","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.jconrel.2024.05.003_bb0145","series-title":"Advances in Carbohydrate Chemistry and Biochemistry","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0065-2318(08)60218-8","article-title":"Carbohydrate Boronates","author":"Ferrier","year":"1978"},{"issue":"12","key":"10.1016\/j.jconrel.2024.05.003_bb0150","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1158\/0008-5472.CAN-16-3119","article-title":"Multifunctional telodendrimer nanocarriers restore synergy of bortezomib and doxorubicin in ovarian cancer treatment synergized BTZ\/DOX combination codelivered by nanocarriers","volume":"77","author":"Wang","year":"2017","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.003_bb0155","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/abe35a","article-title":"Rational nanocarrier design towards clinical translation of cancer nanotherapy","volume":"16","author":"Guo","year":"2021","journal-title":"Biomed. Mater."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.003_bb0160","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1021\/acsomega.1c06558","article-title":"Phenylboronic-acid-based functional chemical materials for fluorescence imaging and tumor therapy","volume":"7","author":"Li","year":"2022","journal-title":"ACS Omega"},{"issue":"42","key":"10.1016\/j.jconrel.2024.05.003_bb0165","doi-asserted-by":"crossref","first-page":"17620","DOI":"10.1021\/ja307085h","article-title":"A structure\u2013function relationship for the optical modulation of phenyl boronic acid-grafted, polyethylene glycol-wrapped single-walled carbon nanotubes","volume":"134","author":"Mu","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2024.05.003_bb0170","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jconrel.2022.05.056","article-title":"Preparation and application of pH-responsive drug delivery systems","volume":"348","author":"Ding","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.05.003_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.808799","article-title":"Role of lactate in inflammatory processes: friend or foe","volume":"12","author":"Manosalva","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.jconrel.2024.05.003_bb0180","first-page":"1110","article-title":"Instrumental role for reactive oxygen species in the inflammatory response","volume":"25","author":"Fokam","year":"2020","journal-title":"FBL"},{"issue":"26","key":"10.1016\/j.jconrel.2024.05.003_bb0185","doi-asserted-by":"crossref","first-page":"14630","DOI":"10.1039\/D1TA02308J","article-title":"Recent progress in self-healing polymers and hydrogels based on reversible dynamic B\u2013O bonds: boronic\/boronate esters, borax, and benzoxaborole","volume":"9","author":"Cho","year":"2021","journal-title":"J. Mater. Chem. A"},{"issue":"17","key":"10.1016\/j.jconrel.2024.05.003_bb0190","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1021\/la7008573","article-title":"Fluorescence of amphotericin B-deoxycholate (Fungizone) monomers and aggregates and the effect of heat-treatment","volume":"23","author":"Stoodley","year":"2007","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2024.05.003_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2023.121486","article-title":"Effect of amphotericin B on the thermodynamic stability, aggregation state, hemolysis and antifungal activity of amphotericin B-nonionic surfactant micellar system","volume":"376","author":"Liu","year":"2023","journal-title":"J. Mol. Liq."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.003_bb0200","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/ma10020170","article-title":"Boronic acid as glucose-sensitive agent regulates drug delivery for diabetes treatment","volume":"10","author":"Zhao","year":"2017","journal-title":"Materials"},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.003_bb0205","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/btm2.10014","article-title":"ROS-responsive drug delivery systems","volume":"1","author":"Liang","year":"2016","journal-title":"Bioengineering & translational medicine"},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.003_bb0210","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1039\/C9MD00169G","article-title":"Prodrug strategies for targeted therapy triggered by reactive oxygen species","volume":"10","author":"Cadah\u00eda","year":"2019","journal-title":"MedChemComm"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.003_bb0215","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2958.2008.06528.x","article-title":"Candida albicans cell surface superoxide dismutases degrade host-derived reactive oxygen species to escape innate immune surveillance","volume":"71","author":"Frohner","year":"2009","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jconrel.2024.05.003_bb0220","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semcdb.2018.03.004","article-title":"Oxidative responses and fungal infection biology","volume":"89","author":"Warris","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.003_bb0225","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jconrel.2013.02.026","article-title":"A simple way to enhance Doxil\u00ae therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer","volume":"168","author":"Zhao","year":"2013","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.003_bb0230","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5539\/ijb.v2n1p84","article-title":"Culture and identification of candida albicans from vaginal ulcer and separation of enolase on SDS-PAGE","volume":"2","author":"Bhavan","year":"2010","journal-title":"International Journal of Biology"},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.003_bb0235","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/AAC.45.2.553-562.2001","article-title":"Reduction of NO synthase expression and tumor necrosis factor alpha production in macrophages by amphotericin B lipid carriers","volume":"45","author":"Larabi","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"39","key":"10.1016\/j.jconrel.2024.05.003_bb0240","doi-asserted-by":"crossref","first-page":"37561","DOI":"10.1074\/jbc.M306137200","article-title":"The antifungal drug amphotericin B promotes inflammatory cytokine release by a toll-like receptor-and CD14-dependent mechanism","volume":"278","author":"Sau","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.003_bb0245","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/oxfordjournals.annonc.a057878","article-title":"Intravenous administration of amphotericin B entrapped in liposomes: induction of high serum levels of TNF\u03b1","volume":"2","author":"Sculier","year":"1991","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.jconrel.2024.05.003_bb0250","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1177\/0022034512446486","article-title":"Amphotericin B up-regulates lipid A-induced IL-6 production via Caspase-8","volume":"91","author":"Tamai","year":"2012","journal-title":"J. Dent. Res."},{"issue":"7","key":"10.1016\/j.jconrel.2024.05.003_bb0255","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1021\/acs.molpharmaceut.5b00144","article-title":"Anti-PEG IgM is a major contributor to the accelerated blood clearance of polyethylene glycol-conjugated protein","volume":"12","author":"Mima","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.05.003_bb0260","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.003_bb0265","first-page":"316","article-title":"Euthanasia by CO2 inhalation affects potassium levels in mice","volume":"49","author":"Traslavina","year":"2010","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.003_bb0270","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/ijcep.ijcep_43_17","article-title":"Potassium homeostasis, oxidative stress, and human disease","volume":"4","author":"Udensi","year":"2017","journal-title":"International journal of clinical and experimental physiology"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.003_bb0275","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/08923973.2017.1392564","article-title":"Improvement of icaritin on hematopoietic function in cyclophosphamide-induced myelosuppression mice","volume":"40","author":"Sun","year":"2018","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"11","key":"10.1016\/j.jconrel.2024.05.003_bb0280","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1053-2498(99)00072-8","article-title":"Cyclophosphamide rescue therapy for chronic rejection after lung transplantation","volume":"18","author":"Verleden","year":"1999","journal-title":"J. Heart Lung Transplant."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.003_bb0285","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jac\/48.2.245","article-title":"Treatment of experimental candidosis with amphotericin B-Intralipid admixtures in immunocompromised mice","volume":"48","author":"Shadkchan","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.003_bb0290","first-page":"195","article-title":"Opportunistic invasive fungal infections: diagnosis & clinical management","volume":"139","author":"Badiee","year":"2014","journal-title":"Indian J. Med. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.003_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.jconrel.2024.05.003_bb0300","first-page":"dkad139","article-title":"Invasive candidiasis: current clinical challenges and unmet needs in adult populations","author":"Soriano","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"issue":"11","key":"10.1016\/j.jconrel.2024.05.003_bb0305","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1021\/acs.accounts.9b00292","article-title":"The chemistry of boronic acids in nanomaterials for drug delivery","volume":"52","author":"Stubelius","year":"2019","journal-title":"Acc. Chem. Res."},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.003_bb0310","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s10096-020-03912-w","article-title":"Mechanism of Candida pathogenesis: revisiting the vital drivers","volume":"39","author":"Mba","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.jconrel.2024.05.003_bb0315","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.biomaterials.2017.06.041","article-title":"Riboflavin-containing telodendrimer nanocarriers for efficient doxorubicin delivery: high loading capacity, increased stability, and improved anticancer efficacy","volume":"141","author":"Guo","year":"2017","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.jconrel.2024.05.003_bb0320","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1021\/acsabm.0c00342","article-title":"Rationally designed micellar nanocarriers for the delivery of hydrophilic methotrexate in psoriasis treatment","volume":"3","author":"Guo","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.003_bb0325","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1038\/ncomms8449","article-title":"A drug-specific nanocarrier design for efficient anticancer therapy","volume":"6","author":"Shi","year":"2015","journal-title":"Nat. Commun."},{"issue":"59","key":"10.1016\/j.jconrel.2024.05.003_bb0330","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.1039\/c3cc43209b","article-title":"The core-inversible micelles for hydrophilic drug delivery","volume":"49","author":"Huang","year":"2013","journal-title":"Chem. Commun."},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.003_bb0335","doi-asserted-by":"crossref","DOI":"10.1063\/1.4962992","article-title":"Physical characterization of nanoparticle size and surface modification using particle scattering diffusometry","volume":"10","author":"Clayton","year":"2016","journal-title":"Biomicrofluidics"},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.003_bb0340","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s100960100577","article-title":"Evaluation of five commercial Sabouraud gentamicin-chloramphenicol agar media","volume":"20","author":"Brun","year":"2001","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924002876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924002876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:43:22Z","timestamp":1778730202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924002876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":68,"alternative-id":["S0168365924002876"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.05.003","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cClick\u201d amphotericin B in prodrug nanoformulations for enhanced systemic fungemia treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}